Prospect Medical Offices

Midland Park, New Jersey 07432

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Non-Small Cell Lung Cancer Clinical Trial
M7824 Versus Pembrolizumab as a First-line (1L) Treatment in Participants With Programmed Death-ligand 1 (PD-L1) Expressing Advanced Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling, Phase II
Updated: 12/31/1969
Prospect Medical Offices
mi
from
Midland Park, NJ
Click here to add this to my saved trials